ARTICLE | Clinical News
Pfizer preclinical data
May 11, 2009 7:00 AM UTC
PF-3845 selectively inhibited fatty acid amide hydrolase (FAAH), raised brain anandamide levels for up to 24 hours and significantly reduced cannabinoid receptor-dependent inflammatory pain in rats. ...